Publication:
Effects of potent nitric oxide-guanylyl cyclase activator and phosphodiesterase-5 inhibitor on cognitive deficits in diabetic rats

dc.contributor.authorsUtkan, T.; Ozer, C.; Gacar, N.; Aricioglu, F.
dc.date.accessioned2022-03-12T16:13:54Z
dc.date.accessioned2026-01-11T10:34:51Z
dc.date.available2022-03-12T16:13:54Z
dc.date.issued2012
dc.identifier.doi10.1016/S0924-977X(12)70301-2
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/11424/225138
dc.identifier.wosWOS:000317948600192
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofEUROPEAN NEUROPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEffects of potent nitric oxide-guanylyl cyclase activator and phosphodiesterase-5 inhibitor on cognitive deficits in diabetic rats
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS207
oaire.citation.startPageS207
oaire.citation.titleEUROPEAN NEUROPSYCHOPHARMACOLOGY
oaire.citation.volume22

Files